Citations to this article
Citation Information: J Clin Invest. 2013;123(3):1010-1013. https://doi.org/10.1172/JCI67961.
Abstract
Cardiac muscle restitution, or true regeneration, is an unmet need in the treatment of myocardial infarction (MI), prompting a decade of study with stem cells of many kinds. Among key obstacles to effective cardiac cell grafting are the cost of autologous stem cell–derived cardiomyocytes, the ethical implications of using embryonic stem cell (ESC) products, immunological barriers to allogeneic cells, functional maturation beyond just the correct lineage decision, and the lack of durable engraftment. In this issue of the
Authors
Sara J. McSweeney, Michael D. Schneider
Citations to this article (1)
| Title and authors | Publication | Year |
|---|---|---|
|
Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases
Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D, Quan J, Chen L |
Neuropsychiatric Disease and Treatment | 2025 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)